An examination of the treatment received by patients with myocardial infarction at 80 hospitals in Quebec indicates that those who received either primary percutaneous coronary intervention or fibrinolysis beyond the times recommended in international guidelines had a significantly increased risk of death within 30 days, along with an increased risk of the combined outcome of death or readmission for heart attack or heart failure at one year, according to a new study.